Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.95
+0.18100.52%
Volume:6K
Turnover:223.97K
Market Cap:44.56M
PE:- -
High:35.10
Open:35.10
Low:34.85
Close:34.77
52wk High:35.61
52wk Low:27.36
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.71
T/O Rate:0.50%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly (LLY) Sues Six Companies Over Weight-Loss Drug Sales

TIPRANKS
·
Aug 12

Eli Lilly is Suing Pharmacies and Peptide Vendors over Sales of the Next Big Weight-Loss Drug: Retatrutide

Dow Jones
·
Aug 12

Amplifica Holdings Group: Closes Oversubscribed $26 Mln Series B Preferred Stock Financing Led by Tasso Partners, Participation from Eli Lilly & Co

THOMSON REUTERS
·
Aug 12

Dow Jones Top Company Headlines at 9 am ET: Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs | Brinker ...

Dow Jones
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Eli Lilly Files Six Lawsuits Targeting Black-Market Retatrutide Sellers in US

Reuters
·
Aug 12

Lilly Calls on Online Platforms, Payment Companies and Regulators to Shut Down the Illegal Retatrutide Black Market

THOMSON REUTERS
·
Aug 12

Eli Lilly: Calling on Entities That Sellers Use to Conduct Their Illegal Business-Social Media and E-Commerce Platforms

THOMSON REUTERS
·
Aug 12

Eli Lilly - Reports over 14,000 Unlawful Retatrutide Listings in 100 Countries

THOMSON REUTERS
·
Aug 12

Legend Biotech Corporation : TD Cowen Cuts Target Price to $24 from $29

THOMSON REUTERS
·
Aug 12

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Reuters
·
Aug 12

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

Reuters
·
Aug 12

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12